Platelets retain high levels of active plasminogen activator inhibitor 1

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Brogren, Helén ^a   Wallmark, Karin ^a   Deinum, Johanna ^b   Karlsson, Lena ^a   Jern, Sverker ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRITON X 100;

ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE THAWING; HUMAN; HUMAN CELL; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SCINTIGRAPHY; THROMBOCYTE; THROMBOCYTE ACTIVATION; ULTRASOUND; WESTERN BLOTTING;

BLOOD PLATELETS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMANS; IODINE RADIOISOTOPES; OCTOXYNOL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET ACTIVATION; PLATELET COUNT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84858259144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026762     Document Type: Article

References (38)

1. Erickson LA, Ginsberg MH, Loskutoff DJ, (1984) Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 74: 1465-1472.
2. Robbie LA, Bennett B, Croll AM, Brown PA, Booth NA, (1996) Proteins of the fibrinolytic system in human thrombi. Thromb Haemost 75: 127-133.
3. Booth NA, Robbie LA, Croll AM, Bennett B, (1992) Lysis of platelet-rich thrombi: the role of PAI-1. Ann N Y Acad Sci 667: 70-80.
4. Potter van Loon BJ, Rijken DC, Brommer EJ, van der Maas AP, (1992) The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost 67: 101-105.
5. Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D, (1994) Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and-independent mechanisms. Blood 83: 351-356.
6. Stringer HA, van Swieten P, Heijnen HF, Sixma JJ, Pannekoek H, (1994) Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop. Arterioscler Thromb 14: 1452-1458.
7. Torr-Brown SR, Sobel BE, (1993) Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb Res 72: 413-421.
8. Konstantinides S, Schafer K, Thinnes T, Loskutoff DJ, (2001) Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 103: 576-583.
9. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR, (1988) Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 70: 327-333.
10. Booth NA, Croll A, Bennett B, (1990) The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet. Fibrinolysis 4: 138-140.
11. Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, et al. (1988) Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 71: 220-225.
12. Lang IM, Schleef RR, (1996) Calcium-dependent stabilization of type I plasminogen activator inhibitor within platelet alpha-granules. J Biol Chem 271: 2754-2761.
13. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, et al. (2004) Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 104: 3943-3948.
14. Stathopulos PB, Scholz GA, Hwang YM, Rumfeldt JA, Lepock JR, et al. (2004) Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci 13: 3017-3027.
15. Gils A, Declerck PJ, (1998) Modulation of plasminogen activator inhibitor 1 by Triton X-100-identification of two consecutive conformational transitions. Thromb Haemost 80: 286-291.
16. Andreasen PA, Egelund R, Jensen S, Rodenburg KW, (1999) Solvent effects on activity and conformation of plasminogen activator inhibitor-1. Thromb Haemost 81: 407-414.
17. Nordenhem A, Wiman B, (1997) Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene. Scand J Clin Lab Invest 57: 453-461.
18. Urden G, Chmielewska J, Carlsson T, Wiman B, (1987) Immunological relationship between plasminogen activator inhibitors from different sources. Thromb Haemost 57: 29-34.
19. Gaussem P, Grailhe P, Angles-Cano E, (1993) Sodium dodecyl sulfate-induced dissociation of complexes between human tissue plasminogen activator and its specific inhibitor. J Biol Chem 268: 12150-12155.
20. Bjorquist P, Ehnebom J, Inghardt T, Deinum J, (1997) Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator. Biochim Biophys Acta 1341: 87-98.
21. Levin EG, Santell L, (1987) Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells. Blood 70: 1090-1098.
22. Lindahl TL, Sigurdardottir O, Wiman B, (1989) Stability of plasminogen activator inhibitor 1 (PAI-1). Thromb Haemost 62: 748-751.
23. Kooistra T, Sprengers ED, van Hinsbergh VW, (1986) Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells. Biochem J 239: 497-503.
24. Gram J, Declerck PJ, Sidelmann J, Jespersen J, Kluft C, (1993) Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activity. Thromb Haemost 70: 852-857.
25. (2000) Criteria and search for specific assays for active plasminogen activator inhibitor 1 (PAI-1) in plasma. eJIFCC 12 http://www.ifcc.org/ejifcc/vol12no12/PAI-11assays.htm.
26. Fay WP, Murphy JG, Owen WG, (1996) High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi. Arterioscler Thromb Vasc Biol 16: 1277-1284.
27. Meijer P, Pollet DE, Wauters J, Kluft C, (1994) Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated. Clin Chem 40: 110-115.
28. Kluft CJ, AFH (1990) Comparison of specificieties of antigen assays for plasminogen activator inhibitor 1 (PAI-1). Fibrinolysis 4: 136-137.
29. Declerck PJ, Collen D, (1990) Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb Res Suppl 10: 3-9.
30. Lang IM, Marsh JJ, Moser KM, Schleef RR, (1992) Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets. Blood 80: 2269-2274.
31. Hekman CM, Loskutoff DJ, (1985) Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 260: 11581-11587.
32. Lambers JW, Cammenga M, Konig BW, Mertens K, Pannekoek H, et al. (1987) Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipids. J Biol Chem 262: 17492-17496.
33. Gaussem P, Angles-Cano E, (1991) The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1. Biochim Biophys Acta 1079: 321-329.
34. Declerck PJ, De Mol M, Alessi MC, Baudner S, Paques EP, et al. (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263: 15454-15461.
35. Wiman B, Almquist A, Sigurdardottir O, Lindahl T, (1988) Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma. FEBS Lett 242: 125-128.
36. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
37. Fraker PJ, Speck JC Jr, (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 80: 849-857.
38. Stromqvist M, Andersson JO, Bostrom S, Deinum J, Ehnebom J, et al. (1994) Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1. Protein Expr Purif 5: 309-316.